William Clark Foy, RPH in Mccloud, CA - Pharmacist

William Clark Foy, RPH is a Pharmacist based in Mccloud, California. William Clark Foy is licensed to practice in California (license number 41784) and his current practice location is 837 Hennessy Way, Mccloud, California. He can be reached at his office (for appointments etc.) via phone at (760) 809-8674.

NPI number for William Clark Foy is 1780042945 and his current mailing address is 837 Hennessy Way, Mccloud, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1780042945.

Contact Information

	William Clark Foy, RPH
	837 Hennessy Way, Mccloud, CA 96057
	(760) 809-8674
	Not Available

Healthcare Provider's Profile

Full Name	William Clark Foy
Gender	Male
Speciality	Pharmacist
Location	837 Hennessy Way, Mccloud, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1780042945
Provider Enumeration Date: 02/03/2016
Last Update Date: 02/03/2016

Medical Identifiers

Medical identifiers for William Clark Foy such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1780042945	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	41784 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Clark Foy is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Clark Foy, RPH 837 Hennessy Way, Mccloud, CA 96057 Ph: (760) 809-8674	William Clark Foy, RPH 837 Hennessy Way, Mccloud, CA 96057 Ph: (760) 809-8674

News Archive

Low-level radiation exposure poses less threat to health than modern lifestyle risks

Human populations have always been exposed to ionizing radiation, and more so in modern life due to its use in medicine, industry and the armed forces.

New hospital technology disrupts working practices, forces improvisation to deliver safe patient care

Doctors and nurses must adapt their routines and improvise their actions to ensure continued patient safety, and for their roles to be effective and to matter as new technology disrupts their working practices.

FDA confirms GRAS status for Ajinomoto's AjiGRAS-Leucine

Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.

FDA clears AdvanDx' 90 minutes protocol for C. albicans PNA FISH and C. albicans/C. glabrata PNA FISH tests

AdvanDx today announced that it has received FDA 510(k) clearance for a fast, 90 minutes protocol for its C. albicans PNA FISH® and C. albicans/C. glabrata PNA FISH® tests. The faster protocol reduces the PNA FISH turn-around time from the original 2.5 hours to 90 minutes by reducing PNA probe hybridization from 90 minutes to 30 minutes.

A new method for assessing women's eggs could enhance IVF success

Many couples who have trouble conceiving a child have turned to a process known as in vitro fertilization.

William Clark Foy, RPH - Pharmacist in Mccloud, CA